top of page

Proteo® test (ultra-early cancer risk test)

What is Proteo® Test (ultra-early cancer risk test)?

The Proteo® test uses just one drop of blood to detect cancer from stage 0. When cancer develops in the body, minute amounts of cancer-related substances that dissolve into the blood are measured and quantified using the Proteo®, a new biochip, and the risk of cancer is classified and assessed into three levels: A (low risk), B (needs observation), and C (high risk)*.

The Proteo® test has the advantage that the measured values show clear differences, making it easy to interpret and extremely unlikely to result in a false positive.

Not only can it be used as a tool for early detection of cancer, but it can also be used as a useful test for assessing the risk of progression, recurrence and metastasis, and the effectiveness of treatment.

Sun Clinic Breast Care/Immunocare Proteo Test

*Proteo® is used to assess the risk of cancer, but does not provide a definitive diagnosis. Even if the test is rated A, it does not completely deny the possibility of developing cancer. Also, even if the test is rated B or C, it does not necessarily mean that the cancer will develop. There are cases where the cancer will not develop, or where the test result is due to a cyst, fibroma, polyp, fatty liver, etc.

Cancers targeted by Proteo® testing

The Proteo® test (ultra-early cancer risk test) targets the following solid cancers:

Pancreatic cancer

Lung cancer

Breast cancer

Stomach cancer

Liver cancer

Colon cancer

Tongue cancer

Thyroid cancer

Kidney cancer

Uterine cancer

Ovarian cancer, etc.

Proteo® Testing Method

The test requires a very small amount of blood (30 microliters) taken from the fingertip or other source.

If another blood test is being done at the same time, some of the blood may be used to perform the test.

It is a safe testing method with little physical burden as it is not affected by food, etc.

Precautions for Proteo® Testing

  • Precancerous lesions may be found, and the aim is to prevent them from developing into cancer by treating them.

  • This test is used to assess the risk of cancer, but does not provide a definitive diagnosis.

  • It does not detect cancer with 100% accuracy.

bottom of page